Compare Enveric Biosciences Inc (ENVB) vs TransMedics Group Inc (TMDX) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Enveric Biosciences Inc vs TransMedics Group Inc — how do they compare? Enveric Biosciences Inc trades at $1.45 (market cap $6.20M), while TransMedics Group Inc trades at $89.19 (market cap $3.10B). The key difference: TransMedics Group Inc is far larger — about 500× Enveric Biosciences Inc's market cap, and TransMedics Group Inc is trading nearer its 52-week high, Enveric Biosciences Inc nearer its low. Which is the better fit depends on your goals.
| ENVB | TMDX | |
|---|---|---|
Market Cap | $6.20M | $3.10B |
Sector | Health | Technology |
52-Week High | $17.40 | $150.42 |
52-Week Low | $1.27 | $61.99 |
Enterprise Value | $1.30M | $3.49B |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Enveric Biosciences Inc
Enveric Biosciences is a biotechnology company focused on developing next-generation psychedelic-inspired therapies for mental health and neuropsychiatric disorders.
Read more on ENVB →About TransMedics Group Inc
TransMedics is a pioneering medical technology company that is disrupting the organ transplant market with its Organ Care System (OCS™). By replacing traditional cold storage with portable warm perfusion, the OCS maintains donor organs in a near-physiologic state, allowing for continuous assessment and optimization. Through its National OCS Program (NOP™), TransMedics provides an end-to-end clinical and logistics solution, including a dedicated aviation fleet, to maximize the utilization of donor organs and improve patient outcomes.
Read more on TMDX →
